DD202-114 is a potent and selective GLP1R agonist. DD202-114 inhibits hERG with an IC50 of 15.9 µM. DD202-114 exhibits strong CYP2C8 inhibition with an IC50 of 0.22 µM. DD202-114 promotes cAMP accumulation. DD202-114 reduces blood glucose levels and food intake. DD202-114 has the potential to be used in the study of type 2 diabetes mellitus (T2DM) and obesity[1][2].
Molekulargewicht:
586.65
Reinheit:
98.47
CAS Nummer:
[2886728-09-0]
Formel:
C33H35FN4O5
Target-Kategorie:
Cytochrome P450,GLP Receptor,Potassium Channel
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten